SENP7 and inflammatory bowel disease: Lower sumoylation rates, possibly due to enhanced SENP7 desumoylase activity, were also detected in patients with inflammatory bowel disease and were described as a prerequisite for the onset of inflammation in colons from mice with dextran sodium sulfate- (DSS-) induced colitis [37, 38].